Covant Therapeutics

Covant Therapeutics is a Boston-based covalent drug discovery and development company incubated by Roivant Sciences (NASDAQ: ROIV). Covant creates new therapeutic approaches by covalently targeting and modulating proteins. To discover these therapies, the company leverages cutting-edge capabilities and expertise in chemistry, quantitative proteomics, translational science, and deep learning.